North Tide Capital’s Amedisys AMED Stock Holding History

North Tide Capital’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-500,000	Closed	-$24.2M	–	19
2016 Q1	$24.2M	Sell	500,000 -1,500,000	-75%	-$57.9M	2.62%	11
2015 Q4	$78.6M	Sell	2,000,000 -2,000,000	-50%	-$80M	7.83%	6
2015 Q3	$152M	Hold	4,000,000	–	–	13.24%	3
2015 Q2	$159M	Hold	4,000,000	–	–	11.47%	3
2015 Q1	$107M	Hold	4,000,000	–	–	8.1%	3
2014 Q4	$117M	Hold	4,000,000	–	–	7.89%	3
2014 Q3	$80.7M	Hold	4,000,000	–	–	6.15%	4
2014 Q2	$67M	Buy	4,000,000 +800,000	+25%	+$11.3M	4.68%	6
2014 Q1	$47.6M	Hold	3,200,000	–	–	4.01%	10
2013 Q4	$46.8M	Buy	3,200,000 +450,000	+16%	+$7.25M	4.1%	13
2013 Q3	$47.3M	Buy	2,750,000 +250,000	+10%	+$3.71M	4.96%	8
2013 Q2	$29M	Buy	+2,500,000	New	+$28.6M	5.14%	8

Other funds holding AMED

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

North Tide Capital's AMED Position: Q2 2016 in Review

North Tide Capital sold out of Amedisys (AMED) in Q2 2016, closing a stake of 500,000 shares — an estimated $24.2M sold.

North Tide Capital first reported a position in AMED in Q2 2013 and held it in 12 quarters. The position peaked at $159M in Q2 2015. 168 funds tracked by Wall St. Rank hold AMED as of Q2 2016.

North Tide Capital reported no remaining Amedisys position as of Q2 2016 after selling out during the quarter.
North Tide Capital sold 500,000 Amedisys shares in Q2 2016, an estimated $24.2M.
North Tide Capital first reported a position in Amedisys in Q2 2013 and held it in 12 quarters.
North Tide Capital's Amedisys position peaked at $159M in Q2 2015.
168 funds tracked by Wall St. Rank held Amedisys as of Q2 2016.

Based on North Tide Capital's 13F filing for Q2 2016, filed 15 Aug 2016.